Peter D. Meldrum was a co-founder and has been a Director of the Company since its inception in May 1991, he has served as President and Chief Executive Officer of the Company since November 1991. Prior to joining the Company he was President and Chief Executive Officer of Founders Fund, Inc., a venture capital group. He received a Doctor of Engineering degree (honorary) from the University of Utah in 2009, a Doctor of Science degree (honorary) from Westminster College in 2004, an M.B.A. degree from the University of Utah in 1974, and a B.S. degree in Chemical Engineering from the University of Utah in 1970.
Mark C. Capone, President of Myriad Genetic Laboratories, joined the company in October 2002. He currently serves on the Board of the American Clinical Laboratory Association. Prior to joining Myriad, Mr. Capone served 17 years with Eli Lilly and Company where he held positions as Product Development Manager, Manufacturing Plant Manager, and Area Sales Director. Mr. Capone received his Bachelor of Science degree in Chemical Engineering from Penn State University graduating with highest distinction, his Master of Science degree in Chemical Engineering from Massachusetts Institute of Technology, and his Master of Science in Management from Massachusetts Institute of Technology. In 2012, Mr. Capone was elected Outstanding Engineering Alumnus at Penn State and he is a member of the Industrial and Professional Advisory Council at Penn State.
James S. Evans, Chief Financial Officer, joined Myriad in 1995. Mr. Evans served as Myriad's Corporate Controller from 1995 until July 2005 when he was named Vice President, Finance, a position he held until November 2007 when he was named Chief Financial Officer. Mr. Evans began his career in the Audit/Attestation division of the international accounting firm of KPMG, LLP where he held several positions. He worked as the Controller for Genmark, Inc. and Shaperite Concepts, Ltd. prior to joining Myriad. Mr. Evans received a Bachelor of Science and Master of Accounting degrees from Brigham Young University in 1987 and is a Certified Public Accountant licensed in the State of Utah.
Ralph L. McDade is the President of Myriad RBM. Since August of 2013 he had been seving as Chief Operating Officer. Dr. McDade was formerly Strategic Development Officer for Myriad RBM and was in that position since the company’s inception in 2002. Prior to joining Myriad RBM he was Chief Scientific Officer for Luminex Corporation from 1996-2002 where he was closely involved with the development of xMAP technology. In addition, during this period Dr. McDade was instrumental in securing technology licensing agreements with over 20 strategic partners. He received his Ph.D. in Microbiology from the University of Texas Southwestern Medical School in 1980. Following post-doctoral training at The University of Connecticut Medical Center in Farmington, he held faculty positions at the Rockefeller University in New York and at Louisiana State University School of Medicine in New Orleans.
Mr. Hagstrom has over 25 years of leadership experience in the healthcare industry. Prior to joining Crescendo Bioscience, he was President of Alpha BioPartners, a strategic consulting firm for early-stage biotechnology companies. While at Alpha BioPartners, Mr. Hagstrom co-founded Altheus Therapeutics and Biolytx Pharmaceuticals. Previously, he served as President and CEO of UroCor, a specialty diagnostic services company focused on urological cancers, which he built from start-up through market launch, product expansion and penetration of over 35 percent of the U.S. urology market. Mr. Hagstrom also has held a variety of management positions in large, multinational healthcare companies including Becton, Dickinson and Company, American Hospital Supply and Baxter International. He received a BS degree in Business Management from Bob Jones University.
Robert G. Harrison, Chief Information Officer, joined Myriad in 1996. Mr. Harrison served as Myriad's Network Administrator from 1996 to 2000. He was then named Director of Information Systems and Technology from 2000 until January 2005. He was then named Vice President of Information Systems and Technology, a position he held until January 2008 when he was named Chief Information Officer. Mr. Harrison began his career in IT working for several private companies and consulting firms where he held several positions in technical support, sales and management capacities. Mr. Harrison received a Bachelor of Science degree in Business Administration with a minor in Computer Science from the University of Utah in 1994.
Jayne B. Hart joined Myriad in May, 2011 as Executive Vice President, Human Resources. Jayne brings over twenty years of professional experience in the human resources field. Prior to joining Myriad, Jayne served as VP, Human Resources at LANDesk Software, a global software company. She has also served previously as VP, Human Resources for 360networks, a wholesale telecom company, and at AT&T Wireless, a global telecom company where she began her career. In her role, Jayne will continue to build upon a culture recognized for attracting, developing and retaining exceptional people.
Gary A. King joined the company in July 2010. Mr. King has been employed in the life sciences industry for more than 25 years. Most recently he was the Chief Executive Officer of AverDx Incorporated, an international biotechnology company. Prior to AverDx, he was Vice President, International Operations at Biosite Incorporated where he spent six years building and leading all of the Company's commercial activities outside the United States. He established marketing and logistics operations in Germany, France, Italy, the United Kingdom, Netherlands, and Belgium, and he established clinical operations and marketing programs in Asia. Prior to joining Biosite, Mr. King was Division Director in Japan for Guidant Corporation and led Guidant's transition from distributor to direct operations in the Japanese market. Mr. King received his Bachelor of Arts degree in Zoology from Pomona College and a Masters of Business Administration degree from Stanford University.
Jerry Lanchbury, Ph.D., Chief Scientific Officer, joined Myriad in September 2002. Prior to this he was a researcher in molecular immunogenetics at Kings College London. Dr. Lanchbury graduated from the University of Aston, Birmingham, UK. He earned his doctorate in population genetics from the University of Newcastle upon Tyne and subsequently completed his postdoctoral fellowship at the United Medical & Dental Schools of the University of London in Human Disease Genetics. Dr. Lanchbury is a highly respected expert in immunogenetics with more than 100 reviewed research journal publications.
Richard Marsh, Executive Vice President, General Counsel and Secretary joined Myriad in November 2002. Prior to joining Myriad, Mr. Marsh served in various positions at Iomega Corporation including Acting General Counsel, Director of IP and Director of Commercial Legal Affairs. Richard received a Masters of Laws degree in Taxation from Georgetown University Law Center; a law degree from Thomas M. Cooley Law School, graduating magna cum laude; and a Bachelor of Science degree in Accounting from Brigham Young University; and was formerly a Certified Public Accountant.
Ronald Rogers, Executive Vice President of Corporate Communications, joined Myriad in April 2013. Prior to joining Myriad, Mr. Rogers served as Executive Director of Global Media Relations at Merck & Co., Inc. He also worked in communcations roles at Johnson & Johnson, Hoechst Marion Roussel, Eli Lilly and Searle and was a business reporter at Chemical & Engineering News. Ron received a Master of Science degree in Communications and Bachelor of Science degree in Public Relations/Chemistry from Illinois State University. He is a member of the National Association of Science Writers.
Stock Quote (NASDAQ:MYGN)
Provided by eSignal.
Corporate Communications and Media Relations